Arylglycine derivatives for use as glycine transport inhibitors
申请人:NPS Allelix Corporation
公开号:US20040152740A1
公开(公告)日:2004-08-05
The present invention relates to compounds of Formula 1:
1
and salts solvates and hydrates thereof. The invention further relates to pharmaceutical compositions containing said compounds and methods of treating neurological and neuropsychistric disorders using said compounds.